What to Know About Leqembi, the Alzheimer ’s Drug Approved by the FDA
Medicare will cover much of the cost for patients in the early stages of the disease, but Leqembi has safety risks and can only modestly slow cognitive decline.
Source: NYT Health - Category: Consumer Health News Authors: Pam Belluck Tags: your-feed-science Alzheimer ' s Disease Health Insurance and Managed Care Medicare Content Type: Service Drugs (Pharmaceuticals) Brain Food and Drug Administration Source Type: news
More News: Alzheimer's | Brain | Food and Drug Administration (FDA) | Health | Health Insurance | Insurance | Managed Care | Medicare | Neurology | Science